Apellis Plans to Seek Re-Examination Following Negative Chmp Opinion for Pegcetacoplan for Geographic Atrophy (Ga) in the EU
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.